Objectives: We sought to determine if an underlying mechanism of the association between
prolonged symptom-to-treatment times and adverse outcomes may be an association of …

BACKGROUND: The CAPTIM trial suggested a survival benefit of prehospital fibrinolysis
(FL) compared to primary percutaneous coronary intervention (PCI) in patients with ST …

In patients with acute ST-elevation myocardial infarction (STEMI), a strategy of prehospital
reduced dose fibrinolytic administration coupled with urgent percutaneous coronary …

BACKGROUND: In contemporary practice, the degree to which fibrinolytic therapy is
administered in a timely fashion for ST-segment elevation myocardial infarction (STEMI) and …

Background Timely reperfusion after ST‐elevation myocardial infarction (STEMI) improves
survival. Guidelines recommend primary percutaneous coronary intervention (PPCI) within …

Background It is not known whether prehospital fibrinolysis, coupled with timely coronary
angiography, provides a clinical outcome similar to that with primary percutaneous coronary …

Background Time-to-treatment is important for survival in patients with acute myocardial
infarction (AMI) treated with fibrinolytic therapy, but the importance of time-to-treatment with …

Although a fibrinolytic pharmacoinvasive strategy is recommended for patients with ST
elevation myocardial infarction (STEMI) unable to undergo timely primary percutaneous …

Background Patients with a myocardial infarction with ST-segment elevation who present to
hospitals that do not have the capability of performing percutaneous coronary intervention …

BACKGROUND: Previous reports have suggested an impact of patient's risk profile and
percutaneous coronary intervention (PCI)–related time delay on the benefits of primary …